Physician profile
Ryan R Snyder
NPI 1477597037
$927.15
in general payments reported to CMS, 2019-2025
14 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $10.99 · 2022: $13.25 · 2023: $563 · 2024: $115 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $424 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $424.48 |
| Food and Beverage | $363.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $442.48 | 2023 | |
| Stryker Corporation | $160.60 | 2023-2025 | Pangea, Gamma, Mako |
| Smith+Nephew, INC. | $92.56 | 2023-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Kvac |
| Titan Surgical Group, LLC | $54.65 | 2024 | |
| Vericel Corporation | $30.81 | 2022-2023 | Maci |
| Pacira Therapeutics, INC. | $23.07 | 2019-2020 | |
| Solventum Corporation | $19.91 | 2025 | Prevena, V.A.C. Veraflo |
| Integra Lifesciences Corporation | $18.67 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.66 | 2019 | |
| Heraeus Medical, LLC. | $15.43 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.26 | 2019 | |
| Pfizer INC. | $12.49 | 2019 | |
| Fidia Pharma USA INC. | $12.42 | 2019 | |
| Merck Sharp & Dohme LLC | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.